MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)

NCT00722371 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1615

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin phosphate
DRUG: Pioglitazone hydrochloride
DRUG: Matching placebo to sitagliptin
DRUG: Matching placebo to pioglitazone
DRUG: Metformin

Sponsor

Merck Sharp & Dohme LLC